Search hospitals > Arkansas > Little Rock
Arkansas Children's Hospital
Claim this profileLittle Rock, Arkansas 72202
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoma
Conducts research for Neuroblastoma
Conducts research for Recurrence
450 reported clinical trials
24 medical researchers
Summary
Arkansas Children's Hospital is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Leukemia, Tumors, Lymphoma, Neuroblastoma, Recurrence and other specialties. Arkansas Children's Hospital is involved with conducting 450 clinical trials across 677 conditions. There are 24 research doctors associated with this hospital, such as David L. Becton, Aravindhan Veerapandiyan, Kevin Bielamowicz, MD, and Stacie Jones, MD.Area of expertise
1Leukemia
Global LeaderStage II
Philadelphia chromosome positive
BCR-ABL1 positive
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
David L. BectonArkansas Children's Hospital6 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
65 reported clinical trials
112 drugs studied
Aravindhan VeerapandiyanArkansas Children's Hospital1 year of reported clinical research
Studies Muscular Dystrophy
Studies Duchenne Muscular Dystrophy
13 reported clinical trials
10 drugs studied
Kevin Bielamowicz, MDArkansas Children's Hospital4 years of reported clinical research
Studies Neuroblastoma
Studies Leukemia
12 reported clinical trials
23 drugs studied
Stacie Jones, MDArkansas Children's Hospital4 years of reported clinical research
Studies Allergy
Studies Food Allergy
5 reported clinical trials
8 drugs studied
Clinical Trials running at Arkansas Children's Hospital
Acute Lymphoblastic Leukemia
Leukemia
Rhabdomyosarcoma
Astrocytoma
Acute Myeloid Leukemia
Crohn's Disease
Lymphoblastic Leukemia-Lymphoma
Muscular Dystrophy
Acute Leukemia
Low Grade Glioma
Levocarnitine
for Chemotherapy-Related Liver Protection in Leukemia and Lymphoma
This phase III trial compares the effect of adding levocarnitine to standard chemotherapy vs. standard chemotherapy alone in protecting the liver in patients with leukemia or lymphoma. Asparaginase is part of the standard of care chemotherapy for the treatment of acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), and mixed phenotype acute leukemia (MPAL). However, in adolescent and young adults (AYA) ages 15-39 years, liver toxicity from asparaginase is common and often prevents delivery of planned chemotherapy, thereby potentially compromising outcomes. Some groups of people may also be at higher risk for liver damage due to the presence of fat in the liver even before starting chemotherapy. Patients who are of Japanese descent, Native Hawaiian, Hispanic or Latinx may be at greater risk for liver damage from chemotherapy for this reason. Carnitine is a naturally occurring nutrient that is part of a typical diet and is also made by the body. Carnitine is necessary for metabolism and its deficiency or absence is associated with liver and other organ damage. Levocarnitine is a drug used to provide extra carnitine. Laboratory and real-world usage of the dietary supplement levocarnitine suggests its potential to prevent or reduce liver toxicity from asparaginase. The overall goal of this study is to determine whether adding levocarnitine to standard of care chemotherapy will reduce the chance of developing severe liver damage from asparaginase chemotherapy in ALL, LL and/or MPAL patients.
Recruiting2 awards Phase 3
Imatinib + Chemotherapy
for Acute Lymphoblastic Leukemia
This study is evaluating whether a combination of drugs may help treat patients with a specific type of leukemia.
Recruiting2 awards Phase 3
Blinatumomab + Chemotherapy
for Leukemia
This study is evaluating whether a combination of chemotherapy and a monoclonal antibody may be more effective than chemotherapy alone in treating patients with B-lymphoblastic leukemia or B-ly
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Arkansas Children's Hospital?
Arkansas Children's Hospital is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Leukemia, Tumors, Lymphoma, Neuroblastoma, Recurrence and other specialties. Arkansas Children's Hospital is involved with conducting 450 clinical trials across 677 conditions. There are 24 research doctors associated with this hospital, such as David L. Becton, Aravindhan Veerapandiyan, Kevin Bielamowicz, MD, and Stacie Jones, MD.
Where is Arkansas Children's Hospital located?
**Arkansas Children's Hospital Location:**
- **Address:** 1 Children's Way, Little Rock, AR 72202.
- **Directions:** From I-630, take Exit 2B to Dr. Martin Luther King Jr. Blvd, then turn onto Children's Way.
Who should I call to ask about financial aid or insurance network?
**Arkansas Children's Hospital Financial and Insurance Information:**
- **Financial Assistance:** For inquiries, contact the Admissions Office at 501-364-1230 or toll-free at 1-800-280-1230.
- **Insurance and Managed Care Inquiries:** Reach an English or Spanish-speaking counselor at 501-364-1230.
- The hospital accepts a variety of insurance plans and provides financial assistance programs for eligible patients.
What insurance does Arkansas Children's Hospital accept?
Arkansas Children's Hospital accepts a wide range of insurance plans, including but not limited to AETNA, American LifeCare, AR BCBS – Arkansas First Source, Cigna, Coventry Health Care, Humana, Medicaid, Medicare, Tricare, and United Healthcare. They offer both a Preferred Provider Option (PPO) and a High Deductible Health Plan (HDHP) through BlueAdvantage Administrators of Arkansas. For specific details regarding coverage and restrictions, contacting the hospital directly or consulting with your insurance company is recommended.
What awards or recognition has Arkansas Children's Hospital received?
Arkansas Children's Research Institute (ACRI) secures over $21 million annually in grants and contracts, underscoring its commitment to academic integrity and effective conflict of interest management. Arkansas Children's Hospital boasts prestigious accolades such as the Gold-Level Beacon Award for Excellence, Magnet status, and Gold Certified Safe Sleep Champion recognition. These awards highlight the hospital's dedication to critical care excellence, nursing excellence, and infant safety.